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ABSTRACT
Low concentrations of the essential amino acid histi-
dine in circulation have been shown to increase mam-
mary blood flow and it has been suggested that this
effect is mediated by histamine. The hypotheses tested
in this experiment were that interstitial histamine con-
centrations in the mammary gland are related to arte-
rial His concentrations and that mammary blood flow
is reduced by extracellular histamine via H1 receptors.
The hypotheses were tested by infusing saline or chlor-
pheniramine, a blocker of the H1 histamine receptor,
into the arterial supply of the mammary glands of lac-
tating cows infused with 44 g/h of amino acid mixtures
with or without His for 10 h. Infusates were adminis-
tered in a 2 × 2 factorial arrangement within a 4 × 4
Latin square to 4 multiparous Holstein cows in mid
lactation. Exclusion of His from the infusate decreased
protein content in milk from the infused udder half
from 3.98 to 3.77%, and increased arterial α-amino-
nitrogen concentration from 3.2 to 3.4 mM. Neither the
decreased arterial His concentration nor the H1 blocker
affected plasma flow to the infused udder half. We con-
clude that histamine is not involved in the regulation
of mammary blood flow. The H1 blocker decreased milk
production in the infused udder half from 4.6 to 3.5 kg
without affecting protein, fat, and lactose percentages,
suggesting an inhibition ofmilk ejection. Cows on chlor-
pheniramine ate less feed during the infusion than sa-
line-infused cows, which resulted in lower arterial con-
centrations and mammary uptakes of acetate. The effi-
ciency of plasma triacylglycerol uptake across the
mammary glands was decreased by chlorpheniramine
but net uptake of long-chain fatty acids was not af-
fected. The mechanism by which an amino acid defi-
ciency influences mammary blood flow does not involve
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histamine signaling through the H1 receptor and re-
mains unidentified.
Key words: histidine, histamine, mammary plasma
flow, dairy cow
INTRODUCTION
To sustain milk synthesis the mammary gland de-
pends on an adequate vascular supply of nutrients,
where mammary blood flow is thought to play an im-
portant role (Davis and Collier, 1985). In general, mam-
mary blood flow correlates closely with milk production
in ruminants (Linzell, 1974; Nielsen et al., 1990), which
indicates that mammary blood flow, like flow to other
tissues, is related to the metabolic activity of the mam-
mary gland (Prosser et al., 1996). By extension, if circu-
lating concentrations of milk precursors affect meta-
bolic activity of the mammary gland, then they should
also affect its rate of blood flow. When circulating con-
centrations of glucose were increased from 3.6 to 6.4
mM by close arterial infusion for 10 h, mammary
plasma flow decreased by 16% (Cant et al., 2002). Simi-
larly, when circulating concentrations of the essential
amino acid His were reduced from 73 to 8M by aboma-
sal infusion of a His-lacking amino acid mix for 6 d,
mammary plasma flow increased by 33% (Bequette et
al., 2000).
Blood flow rate depends on vascular resistance to
the arteriovenous pressure gradient. Locally produced
compounds such as adenosine, CO2, prostaglandins,
andNOhave been shown to relax the resistance to blood
flow in the mammary glands (Linzell, 1974; Nielsen et
al., 1995; Lacasse et al., 1996). It has been proposed that
the nutrient effect on mammary blood flow is related to
the interstitial release of such vasoactive agents as a
consequence of over- or underproduction of ATP relative
to its utilization (Cant and McBride, 1995; Cant et al.,
2003). According to this ATP balance hypothesis, Cant
et al. (2003) suggested that decreased plasma concen-
trations of the energy metabolites acetate and β-hy-
droxybutyrate, characteristic of an amino acid defi-
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ciency in lactating cows (Weekes et al., 2006), could
account for the observed hyperemia in His-deficient
goats (Bequette et al., 2000). However, energy metabo-
lites and mammary blood flow have not been measured
simultaneously in the same His-deficient animals, so
the explanation remains tenuous at best.
An alternative explanation of the low His-induced
hyperemia is due to local production of histamine, as
histamine has been shown to have vasoactive effects in
several tissues (Buckley et al., 1988; Parsons et al.,
1992). Histamine can be both vasoconstrictive and vaso-
dilatory. Vasodilation appears to be due to release of
relaxation factors from the vascular endothelium upon
activation of either H1 or H2 receptor (Jin et al., 2006;
Sta¨hli et al., 2006). Vasoconstriction, on the other hand,
is mediated in the absence of endothelium by H1 recep-
tors (Satoh and Inui, 1984; Jin et al., 2006; Sta¨hli et
al., 2006). At low concentrations, histamine dilated
mammary arteries from humans in vitro, but con-
stricted at greater concentrations (Sta¨hli et al., 2006).
At all concentrations, histamine exerted contractile ef-
fects onmammary arteries from nonlactating goats (Ja-
kobsen et al., 1994). The enzyme for synthesis of hista-
mine from His, histamine decarboxylase, has been de-
tected in mast cells and epithelial cells of the bovine
and murine mammary gland (Maslinski et al., 1993).
If histamine release into the mammary interstitium is
directly related to arterial His concentration and hista-
mine is constrictive to mammary blood flow, then a
temporary His deficiency would be expected to increase
mammary blood flow.
The hypotheses tested in this experiment were that
interstitial histamine is related to arterial His concen-
tration and that mammary blood flow is reduced by
extracellular histamine via H1 receptors. The hypothe-
ses were tested by infusing chlorpheniramine (CPA),
a blocker of the H1 histamine receptor, into the arterial
supply of the mammary glands of lactating cows given
amino acid mixtures with or without His for 10 h. If His
is constrictive to mammary blood flow via H1-receptors,
then CPA should increase flow.
MATERIALS AND METHODS
All animal procedures and holding facilities were ap-
proved by theAnimalCareCommittee at theUniversity
of Guelph. Four second-lactation Holstein cows at 223
± 20 DIM and averaging 606 ± 11 kg of BW and 30 ±
1 kg/d milk were assigned to the present experiment.
The cows were fitted with polyurethane catheters in
both subcutaneous mammary abdominal veins and
with polyethylene catheters in both external iliac arter-
ies via the saphenous arteries. The external iliac posi-
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Table 1. Chemical composition of feedstuffs
Item Concentrate Hay TMR
Composition of TMR, % of as fed 44 56
DM, % of as fed 87.2 90.0 88.8
CP, % of DM 11.2 16.9 14.4
Buffer solubility, % of CP 24.8 47.6 40.0
NDF insolubility, % of CP 5.8 16.4 12.9
ADF insolubility, % of CP 1.8 8.5 6.3
NDF, % of DM 10.4 53.3 34.8
ADF, % of DM 3.3 43.1 25.9
Cellulose, % of DM 3.3 36.1 21.9
Lignin, % of DM 0.0 7.0 4.0
Fat, % of DM 8.1 0.7 3.9
Ash, % of DM 4.4 8.3 6.6
Ca, % of DM 0.56 0.80 0.71
P, % of DM 0.47 0.30 0.38
Mg, % of DM 0.17 0.20 0.19
Calculated NEL, Mcal/kg of DM1 2.06 1.20 1.57
1Calculated according to NRC (2001).
tion was confirmed by injection of Evans blue into the
arterial catheter (Cant et al., 2001).
Cows were housed in tie stalls bedded with wood
shavings. They were milked and fed a TMR low in pro-
tein at 0800 and 1800 h daily. The ration was composed
of 44% concentrate (85% corn, 5% soybean meal, 5%
tallow, and 5% mineral mix on a DM basis) and 56%
chopped, mixed hay (Table 1). Concentrate and hay
were sampled at each feeding and composited for analy-
sis at a commercial laboratory. Before every feeding,
orts were removed and weights recorded. Milking was
performed with a modified bucket milker to collect milk
from each udder half separately.
The experiment was conducted in 2 blocks, with 2
cows in each block, because the facilities only allowed
for sampling from 2 cows at a time. Each cow was ran-
domly assigned to 4 treatments on 4 consecutive days
in a balanced 4 × 4 Latin square design. The 4 treat-
ments were a 2 × 2 factorial arrangement of arterial
infusions of complete andHis-lackingAAmixtureswith
or without CPA. Amino acids were purchased from US-
Biochemical (Cleveland, OH), para-aminohippuric acid
(PAH) was purchased from ICN Biochemicals (Aurora,
OH), and CPA from Sigma Chemical Co. (Oakville, On-
tario, Canada). Solutions of AA (147 g/L) and CPA (3
g/L saline) were prepared the day before infusion. All
solutions were adjusted to pH 7.4 and filtered for steril-
ity through a 0.22-m cellulose acetate filter into auto-
claved polypropylene bottles. Amino acid solutionswere
infused for approximately 10 h between morning and
evening milking through sterile Tygon surgical tubing
into one iliac artery at 5.0 ± 0.2 mL/min. Every 30 min,
either saline or the CPA solution was infused at 5.0 ±
0.2 mL/min for 5 min into the same artery as the AA.
Infusion rates were measured by recording weights of
infusate bottles several times during the day. The AA
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infusion rate amounted to 44 g/h, and the infusion of
CPA amounted to 150 mg/h.
Iliac plasma flow rate was estimated either from the
arteriovenous concentration difference (AVD) of PAH
included in the AA infusates at 16.6 g/L (Cant et al.,
2002), or from the exponential decline of venous PAH
concentration following a rapid injection of approxi-
mately 100 mg of PAH into the external iliac artery
according to Qiao et al. (2005). In either case, at 8, 9,
and 10 h into the infusion, blood samples were with-
drawn with a syringe pump from the external iliac ar-
tery contralateral to infusion and the ipsilateral venous
catheter simultaneously over a period of 10 min. We
used second-lactation cows to avoid the reversal of blood
flow in the pudendal veins that contaminates the mam-
mary arteriovenous difference in cows of third lactation
or higher (Thivierge et al., 2000). Venous anastomoses
between right and left udder halves could also contami-
nate the unilateral arteriovenous difference but we
have observed negligible crossover previously (Cant et
al., 2001), and Metcalf et al. (1992) reported little or no
crossover in cows when standing. Samples were col-
lected from standing cows into EDTAVacutainers (Bec-
ton Dickinson, Franklin Lakes, NJ) on ice. Plasma was
separated by centrifugation for 20 min at 1,500 × g and
4°C, transferred to polypropylene tubes, and stored at
−20°C until analyzed. Milk samples were collected at
the evening milking from each udder half and stored
at 5°C for no more than 2 d before analysis.
Concentrations of PAH in plasma and infusates were
measured as described previously (Cant et al., 2001).
Arterial and venous samples from each cowwere pooled
daily and analyzed for glucose (Sigma kit no. 510-A;
Raabo and Terkildsen, 1960), triacylglycerol (TAG;
Sigmakit no. 336;McGowan et al., 1983), acetate (Boeh-
ringer Mannheim kit; R-Biopharm GmbH, Darmstadt,
Germany; Bergmeyer and Moellering, 1983), BHBA
(Cant et al., 1993), NEFA (NEFA C kit; Wako Chemi-
cals GmbH, Neuss, Germany; Johnson and Peters,
1993), urea (Sigma kit no. 640-B; Chaney andMarbach,
1962), and α-amino N (AAN; Evans et al., 1993). Long-
chain fatty acid concentrations were calculated as 3 ×
TAG (M) + NEFA (M). Protein, fat, and lactose con-
tents of milk samples were measured by infrared spec-
troscopy (AOAC, 1996).
Iliac plasma flow (L/h) was calculated as infusion rate
of PAH (mg/h)/AVD of PAH (mg/L), or as dose of PAH
(mg)/area under venous PAH curve (mgh/L). Local
mammary arterial concentrations of AAN were calcu-
lated as systemic arterial concentration + infused AAN/
iliac plasma flow, and AVD of AAN was calculated as
the difference between milk vein and local arterial con-
centrations. Mammary extraction percentages of blood
metabolites were calculated as the ratio of AVD to arte-
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rial concentration. A change in extraction can arise
from a change in the rate constant for net uptake from
the capillary, k, or the volume of perfused capillaries,
VolcapNcap, due to local vasodilatorymechanisms. Thus,
a kVolcapNcap product was calculated as −ln(1 − extrac-
tion) × iliac plasma flow (Cant and McBride, 1995).
Variance in observations Yijklm was analyzed by the
GLM procedure of SAS version 9 (SAS Institute Inc.,
Cary, NC) according to
Yijklm =  + blocki + cow(block)j(i) + perk + hisl
+ cpam + his × cpalm + εijklm
where  = overall mean, blocki = ith effect of block (i =
1 or 2), cow(block)j(i) = jth effect of cow within block (j =
1 or 2), perk = kth effect of period (k = 1 to 4), hisl = lth
effect of infused His level (l = 1 or 2), cpam = mth effect
of the histamine H1 receptor inhibitor (m = 1 or 2), his
× CPAlm = effect of interaction between the 2 main
effects, and εijklm = random variation, assumed to be
N(0, σ2). Because of missing observations of metabolite
concentrations on d 1 for one of the cows, results were
expressed as least squares means. Statistical signifi-
cance was declared at P < 0.05 and trends were declared
at 0.05 <P ≤ 0.15. To test for treatment carryover effects
from one day to the next in the Latin square design, the
previous day’s treatment was included as a covariate in
the ANOVA model. None of the previous day covariate
effects were significant.
RESULTS
The profile of the AA infusate and the calculated
increase in AA concentrations of the blood supplying
the infused half of the mammary gland are presented
in Table 2. Based on measured rates of iliac plasma
flow, the infusion increased the local mammary mean
arterial plasma concentrations of essential AA and
nonessential AA by 446 and 670 M, respectively.
Subtraction of His from the AA infusate had no effect
on milk or component yields, fat or lactose percentages,
but milk protein content tended to decrease from 3.98
to 3.79 (P = 0.07) on average (Table 3). The histamine
H1 receptor inhibitor CPA decreased feed intake by 20%
(P = 0.02) during the infusion and tended to decrease
milk, protein, fat, and lactose yields (0.05 < P < 0.10).
Therewasno effect of CPA on the proportions of protein,
fat, and lactose in milk. No interactions between His
and CPA infusion were observed in the infused udder
half.
Neither of the infusion treatments affected iliac
plasma flow (Table 4). Systemic arterial concentrations
of AAN tended to increase from an average of 3.18 to
3.42 mM (P = 0.09) when His was removed from the
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Table 2. Amino acid composition of infusate and estimated increase
in mammary plasma AA concentrations at a plasma flow rate of 322
L/h
Local increase in plasma
AA g/L concentration, M
Ala 4.55 53
Arg-HCl 4.84 24
Asp 10.56 82
Cys 1.32 8
Glu 28.60 202
Gly 2.64 37
His-HCl1 3.80 22
Ile 7.77 62
Leu 13.20 105
Lys-HCl 11.59 57
Met 3.52 25
Pro 14.52 131
Ser 8.07 80
Thr 7.04 61
Trp 2.20 11
Tyr 13.49 77
Val 8.95 79
Essential AA 63 446
Nonessential AA 84 670
HCl 1.0
NaOH 10.0
1His was not present in all infusates.
infusate, but close arterial concentrations, extraction
percentages, and uptakes were not affected. Histidine
subtraction tended to increase mammary long-chain
fatty acid uptake from 73 to 86 mmol/h (P = 0.15).
Infusion of CPA decreased arterial and venous concen-
trations of acetate by 25 (P = 0.02) and 35% (P = 0.01),
respectively, and extraction increased from 76 to 80%
(P = 0.01). There was no effect of CPA on the kVolcapN-
cap for acetate, indicating that the dynamics of acetate
uptake were not affected by treatment. Net uptakes of
acetate, in mmol/h, were 23% lower during CPA infu-
Table 3. Least squares means of feed intake, milk yield, and milk contents from the infused udder half
after 10 h of infusion of an AA solution with or without His, and saline or a solution of the histamine H1
receptor inhibitor chlorpheniramine (CPA), into one external iliac artery of 4 cows
Treatment
No His His P-value1
Item No CPA CPA No CPA CPA SEM His CPA His × CPA
Feed intake, kg/d 17.7 14.1 18.2 14.5 1.1 0.71 0.02 0.94
Milk yield, g/h 545 427 539 400 57 0.78 0.06 0.86
Protein
% 3.86 3.68 3.99 3.98 0.10 0.07 0.35 0.39
g/h 19.4 14.9 20.0 15.8 2.1 0.74 0.09 0.95
Fat
% 4.41 4.32 4.50 4.45 0.27 0.68 0.81 0.94
g/h 22.3 18.6 23.2 17.7 2.0 1.00 0.06 0.65
Lactose
% 4.32 4.49 4.36 4.41 0.10 0.81 0.31 0.55
g/h 23.4 19.2 23.4 17.6 2.4 0.76 0.08 0.75
Protein:fat 0.87 0.86 0.89 0.94 0.04 0.33 0.73 0.49
1Probability of no effect of infusion of His, CPA, or their interaction.
Journal of Dairy Science Vol. 91 No. 6, 2008
sion (P = 0.05) because of the lower acetate concentra-
tions in arterial plasma. The kVolcapNcap for TAG and
long-chain fatty acids tended to be decreased by CPA
(0.05 < P < 0.10).
DISCUSSION
Role of Histamine in Mammary Blood Flow
The hypothesis under test in this experiment con-
sisted of 2 parts: first, that histamine release into the
interstitial fluid surrounding the mammary vascula-
ture is directly related to arterial His concentration,
and second, that mammary blood flow is reduced by
interstitial histamine via H1 receptors. According to
this hypothesis, the effect of blocking the H1 receptor
with CPA should be an increase in mammary blood
flow. The effect of a reduced arterial His concentration
should also be an increase in mammary blood flow. No
effect of treatment on iliac plasma flow was observed,
so the hypothesis is rejected.
A decrease in arterial His concentration when His
was subtracted from the infusion of 44 g/h of AA was
evidenced by the 0.22-percentage-unit decrease in milk
protein content, which is similar in magnitude to the
0.16-unit decrease observed when His was subtracted
from 30 g/h of the same infusate (Cant et al., 2001). No
hyperemic response to the low His concentration was
observed in the previous experiment (Cant et al., 2001)
or in the current one. The results suggest that if hista-
mine is indeed vasoactive in the mammary vasculature
it is not released in proportion to concentration of its
precursor, His.
Histamine is synthesized fromHis by histidine decar-
boxylase, and the rate of histamine synthesis is there-
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Table 4. Least squares means of plasma flows and balance of plasma metabolites across the infused udder
half of 4 cows during the last 3 h of a 10-h infusion of an AA solution with or without His, and saline or a
solution of the histamine H1 receptor inhibitor chlorpheniramine (CPA), into one external iliac artery
Treatment
No His His P-value1
Item No CPA CPA No CPA CPA SEM His CPA His × CPA
Plasma flow, L/h 337 326 330 298 17 0.38 0.29 0.60
Glucose
Artery, mM 3.43 2.77 3.58 3.38 0.31 0.31 0.25 0.51
Vein, mM 2.66 2.08 2.58 2.54 0.18 0.39 0.18 0.23
Extraction, % 21.7 25.5 28.2 25.0 3.3 0.44 0.93 0.37
kVolcapNcap,2 L/h 94.1 94.1 109 87.6 11.7 0.76 0.44 0.44
Uptake, mmol/h 282 234 310 255 43 0.61 0.31 0.94
Acetate
Artery, mM 1.10 0.85 1.19 0.86 0.08 0.58 0.02 0.68
Vein, mM 0.25 0.18 0.30 0.18 0.02 0.40 0.01 0.23
Extraction, % 77.3 79.1 74.8 81.0 0.9 0.79 0.01 0.08
kVolcapNcap, L/h 496 497 455 492 34 0.55 0.63 0.65
Uptake, mmol/h 288 229 285 210 24 0.68 0.05 0.76
BHBA
Artery, mM 1.35 1.42 1.39 1.28 0.19 0.86 0.83 0.91
Vein, mM 0.75 0.89 0.81 0.66 0.10 0.46 0.99 0.23
Extraction, % 42.4 38.5 40.7 47.5 4.0 0.44 0.74 0.27
kVolcapNcap, L/h 190 154 174 194 21 0.62 0.74 0.29
Uptake, mmol/h 202 176 195 197 43 0.89 0.80 0.78
Triacylglycerol
Artery, M 140 142 137 137 13 0.81 0.94 0.96
Vein, M 66 77 69 72 7 0.92 0.44 0.64
Extraction, % 53.0 45.0 51.3 49.3 3.6 0.75 0.26 0.47
kVolcapNcap, L/h 276 199 250 210 23 0.78 0.06 0.50
Uptake, mmol/h 26.0 21.9 22.7 19.7 3.0 0.42 0.32 0.87
NEFA
Artery, M 135 144 117 137 18 0.57 0.50 0.80
Vein, M 94 101 93 99 11 0.95 0.60 0.96
Long-chain fatty acids
Artery, M 554 568 529 549 35 0.58 0.66 0.94
Vein, M 292 331 301 315 25 0.90 0.37 0.67
Extraction, % 48.4 42.3 45.5 45.7 3.1 0.95 0.42 0.39
kVolcapNcap, L/h 238 184 214 191 17 0.65 0.09 0.45
Uptake, mmol/h 92.3 79.7 76.5 69.8 7.0 0.15 0.26 0.71
α-Amino N
Opposite artery, mM 3.54 3.30 3.14 3.21 0.11 0.09 0.49 0.25
Artery, mM 4.66 4.34 4.25 4.36 0.11 0.17 0.43 0.14
Vein, mM 3.87 3.87 3.54 3.66 0.22 0.30 0.83 0.81
Extraction, % 16.7 10.6 16.4 16.4 4.1 0.56 0.52 0.53
kVolcapNcap, L/h 66.8 40.0 61.0 54.9 16.3 0.81 0.39 0.58
Uptake, mmol/h 283 167 229 204 58 0.91 0.32 0.50
Urea
Artery, mM 3.52 3.59 3.12 3.45 0.40 0.56 0.67 0.77
1Probabilities of no effect of infusion of His, CPA, or their interaction.
2kVolcapNcap = −Ln (1 − extraction) × iliac plasma flow (Cant and McBride, 1995).
fore expected to follow a dependence on substrate con-
centration, but histamine can be stored intracellularly
before release. Most of the histamine stored in the body
is in mast cells and basophils of the immune system.
The majority of histamine in the mammary glands is
also located in mast cells but histamine and histidine
decarboxylase are also present in the mammary epithe-
lium (Maslinski et al., 1993; Wagner et al., 2003). Upon
stimulation of release, dependent on the cell type and
anatomical location, histamine acts in various roles as
a neurotransmitter or a signal of inflammation and
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other immune responses, gastric acid secretion, or
smooth muscle contraction. After a week of dosing rats
orally with 1 g/kg of His twice daily, histamine concen-
trations in regions of the brain were significantly ele-
vated, but concentrations of the metabolite tele-methyl-
histamine, indicating histamine release, were not af-
fected (Lozeva et al., 2003). Thus, it appears that
release of histamine is a stronger controller of intersti-
tial histamine concentration than concentration of His.
Plasma histamine concentrationswere also not affected
by the His dosing (Lozeva et al., 2003). These observa-
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tions support rejection of the hypothesis that a reduced
arterial His concentration affects histamine concentra-
tion in the mammary vasculature of the lactating
dairy cow.
The lack of a blood flow response to the H1 receptor
blocker CPA allows us to reject the second part of the
hypothesis that histamine is vasoactive in the mam-
mary vasculature via H1 receptors. Histamine has been
shown to exert a combination of constrictive and dila-
tory effects on various arteries, each of which are medi-
ated through separate responsemechanisms. There are
4 histamine receptors, designated H1 to H4 (Wagner et
al., 2003). Antagonists of either the H1 or H2 receptor,
but not both in the same artery, have abolished the
vasodilatory effect of histamine (Jin et al., 2006; Sta¨hli
et al., 2006), which is dependent on precontraction of
the artery and the presence of an intact endothelium
(Jin et al., 2006; Sta¨hli et al., 2006). The net effect of
histamine on isolated arteries at greater concentrations
is constrictive. The vasoconstriction occurs in the ab-
sence of endothelial cells but is abolished by analogs of
the H1 receptor (Jin et al., 2006; Sta¨hli et al., 2006).
The vasoconstriction is thus considered to be due to a
direct effect of histamine on the arterial smooth muscle
or vascular nerves. Internal mammary arteries of the
human were found to be dilatory to histamine at low
concentrations,whereas radial arterieswere not (Sta¨hli
et al., 2006). Both constricted at higher histamine con-
centrations. The pudendal arteries of nonlactating
goats only responded to histamine with vasoconstric-
tion (Jakobsen et al., 1994). In addition, constriction of
the caprine pudendal arteries was inhibited by an H1
receptor blocker (Jakobsen et al., 1994). If the hista-
mine response network behaves in the vasoactive mi-
lieu of the mammary glands in the same way it did in
isolated arteries in vitro, then the antagonist of the H1
receptor should have relaxed resistance to flow, just
as blockers of the adenosine and NO responses affect
mammary plasma flow (Lacasse et al., 1996; Madsen
et al., 2001). However, we observed no effect of CPA on
mammary plasma flow.
An issue that needs to be addressed in interpretation
of our plasma flow results is that the measured plasma
flow was not directed exclusively to the mammary
glands but included femoral arterial flow to the hind
limb. An effect of CPA on plasma flow to the hind limb
could, therefore, either exaggerate or mask effects on
mammary plasma flow. As with other arteries, both
dilation and constriction of the cutaneous and femoral
arteries have been observed, mediated by H1 receptors
(Clough et al., 1998; Arai and Chiba, 1999), so there is
no consensus on how blood flow to the hind limb might
be affected by CPA infusion. However, as discussed by
Cant et al. (2002) and in agreement with measurement
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in lactating goats of blood flow simultaneously in the
external iliac and external pudendal arteries (Bequette
et al., 2001), mammary blood flow accounts for at least
80% of the iliac flow. This means that even a relatively
large change in flow to the hind limb will have only
minor effects on the iliac flow. Thus, our conclusion is
that H1 receptors in the mammary gland are not in-
volved in bovine mammary blood flow regulation in
vivo.
Role of Histamine in Milk Secretion
Although H1 receptors did not influence mammary
blood flow, there was a local effect of histamine medi-
ated by H1 receptors on milk yield. Yield from the in-
fused udder half was negatively affected by infusion of
CPA, whereas no effect was seen on milk yield from
the noninfused udder half (data not shown). It has been
suggested that histamine plays a role in milk ejection
through effects on smoothmuscle contraction (Eriksson
et al., 1999). If this effect is mediated by H1 receptors,
it would explain the negative effect of CPA on milk
yield. Milk fat content decreased by 16% when milk
ejection was inhibited by continuous epinephrine infu-
sion into goats (Leenanuruksa and McDowell, 1985)
but we observed no effect on percentages of protein, fat,
or lactose in milk.
The observation that feed intake dropped when CPA
was infused indicates that CPA not only acted locally
but also had a systemic effect. Intraperitoneal injection
of the H1 blocker dexbrompheniramine into goats at 2
mg/kg of BW0.75 did not affect feed intake (Rossi et al.,
1998). Our arterial infusion over 10 h amounted to a
6-fold higher dose of 12 mg/kg of BW0.75 chlorphenira-
mine. Histamine in several species affects gastrointes-
tinal blood flow by a vasodilatory effect mediated by H1
receptors (Buckley et al., 1988; Rydning et al., 2001).
It is therefore possible that blockade of the H1 receptors
over 10 h compromised gastrointestinal blood flow and
thereby affected digestion and feed intake negatively.
A direct effect on appetite centers in the brain does not
seem likely, because histamine actually depresses feed
intake and blockade of the H1 receptors attenuates this
effect (Masaki et al., 2001).
The decrease in arterial concentration of acetate
when CPA was infused was likely a consequence of
the putative CPA effect on the gastrointestinal tract
because endogenous production of acetate is relatively
low compared with the exogenous supply in ruminants
(Pethick et al., 1981). The 25% lower acetate concentra-
tion resulted in a 23% decrease in acetate uptake by
the mammary glands, but no change in milk output of
its product, fat, relative to the other products, protein
and lactose.
HISTAMINE AND MAMMARY BLOOD FLOW 2467
There was also a decrease (P = 0.06) in the kVolcapN-
cap product for TAG with CPA infusion that accounted
for a decrease (P = 0.09) in kVolcapNcap for long-chain
fatty acids. Because iliac plasma flow was not affected,
the volume of perfused capillaries, VolcapNcap, can be
assumed to have remained constant between treat-
ments, meaning that a drop in efficiency, k, of TAG
uptake occurred. Disappearance of TAG between artery
and vein is due to activity of endothelial lipoprotein
lipase. We are unaware of a connection between the H1
receptor and lipoprotein lipase activity, but there is a
connection between histamine and heparin that may
be significant. Heparin is stored in and released from
mast cells, which also happen to be the major site of
histamine storage in the body and themammary glands
(Maslinski et al., 1993). Heparin in the vascular lumen
knocks mature lipoprotein lipase off the endothelium
to severely decrease arteriovenous TAG hydrolysis (Au-
gustus et al., 2003). Antagonism of the H1 receptor may
have interfered with the control of heparin release from
mast cells and caused disengagement of lipoprotein li-
pase from the mammary endothelium. Although effi-
ciency of TAG hydrolysis may have been reduced by
CPA, net uptake of long-chain fatty acids across the
mammary glands was not significantly affected.
Finding that CPA decreased feed intake and circulat-
ing concentrations of a milk precursor (acetate) raises
the possibility that the reduced nutrient supply may
have elicited a decrease in the rate of synthesis of milk
components. A lower milk synthesis rate would be ex-
pected to decrease mammary blood flow (Linzell, 1974;
Nielsen et al., 1990), countervailing the increase in
mammary blood flow expected from the working hy-
pothesis behind this experiment. However, the decline
in milk yield in cows severely restricted in DMI did not
commence until after 18 h of restriction (Toerien and
Cant, 2007), and complete starvation of goats only
caused a 10% decrease in milk yield after 8 h (Linzell,
1967). Thus, the likelihood of a nutrition-mediated de-
crease in mammary blood flow in this experiment,
masking a CPA-mediated increase in flow, is negligible.
Role of AA in Mammary Blood Flow
It has been suggested that a deficient exogenous sup-
ply of individual AAmay influence the rate ofmammary
blood flow in ruminants (Guinard and Rulquin, 1995).
One of the AA that has been identified as potentially
deficient for milk production is His (Vanhatalo et al.,
1999). In the present study, cows were fed a low-protein
diet and supplied with 44 g/h of exogenous AA, equiva-
lent to approximately one-third of the total metaboliz-
able AA supply, with or without His. Although a tempo-
rary His deficiency was apparent in the milk protein
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depression typical of the short-term infusion protocol,
and in the increase in plasma AAN concentration, iliac
plasma flow did not change. This finding lies in contrast
to the 33% increase in mammary blood flow observed
in goats subjected to a deficiency of approximately 45%
of the metabolizable His supply for 6 d (Bequette et al.,
2000). The hyperemiamay require a few days to develop
because of responses to the His deficiency that occur in
extramammary organs of the cow. Although we have
previously shown, with a simulation model of ATP bal-
ance in themilk-synthesizing system (Cant et al., 2003),
that changes in circulating concentrations of energy
metabolites due to extramammary effects can account
for mammary hyperemias observed in response to both
Met (Guinard and Rulquin, 1995) and His (Bequette et
al., 2000) supply, no rigorous test of that hypothesis
has been conducted. Themechanism bywhich an amino
acid deficiency influences mammary blood flow does not
involve histamine signaling through the H1 receptor
and remains unidentified.
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